Breaking News Instant updates and real-time market news.

TSLA

Tesla

$355.17

-1.74 (-0.49%)

, LLL

L3 Technologies

$177.56

0.98 (0.55%)

10:25
08/08/17
08/08
10:25
08/08/17
10:25

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Tesla (TSLA) upgraded to Buy from Hold at Argus with analyst William Selesky saying he expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in fiscal 2019. 2. L3 Technologies (LLL) upgraded to Buy from Hold at Drexel Hamilton analyst Pete Skibitski saying he is "cautiously" optimistic that there will be a positive resolution in fiscal 2018 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed. 3. Foot Locker (FL) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Jay Sole saying he believes share weakness related to investor concerns surrounding share loss to Amazon (AMZN) and brands' own websites has created an "excellent" buying opportunity. 4. UPS (UPS) upgraded to Buy from Neutral at Citi with analyst Christian Wetherbee saying he sees a "clear path" toward double-digit earnings growth returning in 2018. 5. Cognizant (CTSH) upgraded to Buy from Hold at Berenberg with analyst Georgios Kertsos saying the market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TSLA

Tesla

$355.17

-1.74 (-0.49%)

LLL

L3 Technologies

$177.56

0.98 (0.55%)

FL

Foot Locker

$50.83

1.985 (4.06%)

UPS

UPS

$112.78

0.92 (0.82%)

CTSH

Cognizant

$69.59

-1.59 (-2.23%)

  • 08

    Aug

  • 08

    Aug

  • 09

    Aug

  • 18

    Aug

  • 21

    Aug

  • 02

    Oct

TSLA Tesla
$355.17

-1.74 (-0.49%)

08/08/17
ARGS
08/08/17
UPGRADE
Target $444
ARGS
Buy
Tesla upgraded to Buy from Hold at Argus
08/03/17
BOFA
08/03/17
NO CHANGE
Target $155
BOFA
Underperform
Tesla price target lowered to $155 from $165 at BofA/Merrill
BofA/Merrill analyst John Murphy said Tesla's Q2 results were a bit noisy, but generally above expectations. He said Model 3 ramp volume still remains unclear and expects it to take some time before it reaches any material scale, which could lead to production costs outweighing potential benefits of higher volume operating leverage for an extended time. The analyst expects Tesla will need to raise capital by year-end and believes investor patience will wear thin as further capital raises are net met with improving earnings, cash flow, or returns. Murphy lowered Tesla's price target to $155 from $165 on slightly lower forward estimates and maintains an Underperform rating.
08/03/17
UBSW
08/03/17
NO CHANGE
Target $185
UBSW
Sell
Tesla Model 3 margins look challenging, says UBS
UBS analyst Colin Langan noted Tesla reported Q2 results that beat expectations, but he said the company's capital spending guidance implies more cash burn. Also, its second half margin guidance was worse than he expected, noted Langan, who reiterated his Sell rating and $185 price target on Tesla shares.
08/08/17
ARGS
08/08/17
UPGRADE
Target $444
ARGS
Buy
Tesla upgraded to Buy on strong Model 3 orders at Argus
As previously reported, Argus analyst William Selesky upgraded Tesla to Buy from Hold and set a $444 price target on the shares. He noted that Tesla has been getting 1,800 Model 3 orders per day without any advertising or marketing so far. While he notes the ramp-up of the mass market vehicle will lead to increased labor and overhead costs he expect those to diminish over the course of next year. Selesky now expects Tesla to reach breakeven two quarters earlier than he'd previously forecast and sees the company achieving full-year profitability in FY19.
LLL L3 Technologies
$177.56

0.98 (0.55%)

08/08/17
DRXL
08/08/17
UPGRADE
DRXL
Buy
L3 Technologies upgraded to Buy from Hold at Drexel Hamilton
08/07/17
08/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Deere (DE) upgraded to Conviction Buy from Buy at Goldman Sachs. 2. Chemours (CC) upgraded to Neutral from Sell at UBS with analyst John Roberts saying Chemours' execution has disproved his prior concerns. 3. BP (BP) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company's cash flow generation is in the early stages of a "multi-year positive inflection" while Macondo headwinds are subsiding. 4. L3 Technologies (LLL) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Nosh Poponak saying he favors increased exposure to Defense given the current industry cycle position, geopolitics, and Department of Defense budget dynamics. 5. Illumina (ILMN) upgraded to Buy from Hold at Canaccord with analyst Mark Massaro saying he sees a strong upgrade cycle for NovaSeq beginning in the tird quarter and lasting for three years. He believes we remain in the early innings on major waves of cancer growth and expects the continuation of robust growth of direct to consumer products, such as 23andMe, ancestry.com and now Helix. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/07/17
GSCO
08/07/17
UPGRADE
Target $204
GSCO
Conviction Buy
L3 Technologies upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Nosh Poponak added L3 Technologies to the Conviction Buy List and raised its price target to $204 from $195 saying he favors increased exposure to Defense given the current industry cycle position, geopolitics, and Department of Defense budget dynamics. Poponak believes revenue growth can grow faster than the group due to new growth drivers and finds valuation attractive.
08/08/17
08/08/17
UPGRADE
Target $204

Buy
L3 Technologies upgraded to Buy at Drexel Hamilton
As previously reported, Drexel Hamilton upgraded L3 Technologies and established a $204 price target. Analyst Pete Skibitski is "cautiously" optimistic that there will be a positive resolution in FY18 budget negotiations, which will benefit the entire space, and notes L3's international outlook has improved as the year has progressed.
FL Foot Locker
$50.83

1.985 (4.06%)

08/08/17
MSCO
08/08/17
UPGRADE
MSCO
Overweight
Foot Locker upgraded to Overweight from Equal Weight at Morgan Stanley
08/08/17
08/08/17
UPGRADE
Target $65

Overweight
Foot Locker upgraded to Overweight on recent share weakness at Morgan Stanley
As previously reported, Morgan Stanley upgraded Foot Locker (FL) to Overweight from Equal Weight and trimmed its price target to $65 from $70. Analyst Jay Sole believes share weakness related to investor concerns surrounding share loss to Amazon (AMZN) and brands' own websites has created an "excellent" buying opportunity. The analyst said Amazon and Foot Locker target different segments, with less than 5% of Foot Locker's 200 top selling shoes on Amazon, and brands desire the strong, premium mall presence that Foot Locker provides. Sole thinks recent weak comp performance was due to changing fashion trends, February's tax refund shift, and weaker sales in basketball footwear and for the company to surprise the Street by returning to 3%-5% comp growth in upcoming quarters.
07/20/17
ADAM
07/20/17
NO CHANGE
ADAM
Investors should be selective in 'tired' athletic category, says Canaccord
Canaccord analyst Camilo Lyon said the athletic retail category is tired due to both the Amazon (AMZN) effect and the deceleration in North America that tipped last year when The Sports Authority and other sporting retailers went bankrupt. The analyst believes apathy about owning retail also weighs on the group, but it is ignoring the cyclical issue. He believes investors should be more selective and lowered his price target on Foot Locker (FL) to $64 from $75, on Dick's (DKS) to $52 from $54 and on Hibbett Sports (HIBB) to $22 from $25.
08/01/17
FBCO
08/01/17
NO CHANGE
Target $52
FBCO
Neutral
Foot Locker price target lowered to $52 from $66 at Credit Suisse
Credit Suisse analyst Christian Buss lowered his price target for Foot Locker (FL) to $52 from $66 given increasing industry headwinds and following disappointing commentary by peers Finish Line (FINL) and Hibbett Sports (HIBB). The analyst believes the best-in-class execution by Foot Locker may no longer be enough. He reiterates a Neutral rating on Foot Locker's shares.
UPS UPS
$112.78

0.92 (0.82%)

06/06/17
06/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Hartford Financial (HIG) initiated with a Buy at Deutsche Bank. 2. FedEx (FDX) and UPS (UPS) were initiated with a Neutral at Seaport Global. 3. Gardner Denver (GDI) was initiated with an Outperform at William Blair and Baird, an Overweight at Piper Jaffray, a Buy at Stifel, UBS, and Goldman Sachs, as well as a Neutral at Credit Suisse. 4. Solaris Oilfield (SOI) was initiated with an Outperform at Wells Fargo, Oppenheimer, Evercore ISI, and Credit Suisse, an Overweight at Piper Jaffray, as well as a Buy at Goldman Sachs and Wunderlich. 5. LeMaitre (LMAT) initiated with a Hold at Craig-Hallum. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/29/17
BERN
06/29/17
NO CHANGE
BERN
UPS, FedEx to benefit from growth of e-commerce, says Bernstein
Bernstein analyst David Vernon says that UPS (UPS) and FedEx (FDX) will benefit from the growth of e-commerce because the cost of labor for e-commerce deliveries is set to rise significantly. As labor costs increase, the companies' higher productivity will become more valuable, according to Vernon. The analyst keeps a Market Perform rating on FedEx and an Outperoform rating on UPS.
08/08/17
SBSH
08/08/17
UPGRADE
Target $128
SBSH
Buy
UPS upgraded to Buy from Neutral at Citi
Citi analyst Christian Wetherbee upgraded UPS to Buy with a $128 price target saying he sees a "clear path" toward double-digit earnings growth returning in 2018. The Saturday rollout and currency hedging has masked core growth in 2017, the analyst argues.
07/28/17
AGIS
07/28/17
NO CHANGE
Target $126
AGIS
Buy
UPS lack of guidance increase viewed negatively by investors, says Aegis
Aegis analyst Jeffrey Kauffman said "many investors" were concerned that UPS management didn't raise guidance after the company's "quality EPS surprise" in Q2, but he attributes that to the company's preference to remain conservative. The analyst, who sees positive developments in terms of volume and price being masked in the near-term by currency and investment expenses, keeps a Buy rating on UPS shares and raised his price target to $126 to $124.
CTSH Cognizant
$69.59

-1.59 (-2.23%)

08/04/17
FBCO
08/04/17
NO CHANGE
Target $80
FBCO
Outperform
Cognizant price target raised to $80 from $70 at Credit Suisse
After its Q2 report, Credit Suisse analyst Charles Brennan said Cognizant (CTSH) remains one of the fastest growing companies in Computer Services & IT Consulting and deserves a valuation more in line with slower-growing peer Accenture (ACN). The analyst raised his price target on Cognizant to $80 from $70 and keeps an Outperform rating on the shares.
08/08/17
BREN
08/08/17
UPGRADE
Target $85
BREN
Buy
Cognizant upgraded to Buy from Hold at Berenberg
08/04/17
LOOP
08/04/17
UPGRADE
Target $83
LOOP
Buy
Cognizant upgraded to Buy from Hold at Loop Capital
Loop Capital analyst Joseph Vafi upgraded Cognizant to Buy from Hold as he believes demand headwinds and headline risk are abating. Cognizant has pivoted toward digital services more aggressively than competitors while it still has an overall margin structure below its peers, Vafi tells investors. He raised his price target on Cognizant shares to $83 from $63.
08/08/17
BREN
08/08/17
UPGRADE
Target $85
BREN
Buy
Cognizant upgraded to Buy on less immigration risk at Berenberg
Berenberg analyst Georgios Kertsos upgraded Cognizant Technology Solutions to Buy from Hold and raised his price target for the shares to $85 from $65. The market now considers U.S. immigration policy changes as unlikely, which leaves upside for investors, Kertsos tells investors in a research note. The analyst also thinks upside from potential U.S. tax reforms are not priced into Cognizant shares.

TODAY'S FREE FLY STORIES

ENIA

Enel Americas

$9.25

-0.08 (-0.86%)

19:01
06/17/18
06/17
19:01
06/17/18
19:01
Upgrade
Enel Americas rating change at Goldman Sachs »

Enel Americas upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UL

Unilever; also tag UN

$54.26

0.64 (1.19%)

, UN

Unilever; also tag UL

$54.74

0.7 (1.30%)

18:55
06/17/18
06/17
18:55
06/17/18
18:55
Periodicals
Unilever taking stand against digital media's fake followers, Reuters says »

Unilever, the…

UL

Unilever; also tag UN

$54.26

0.64 (1.19%)

UN

Unilever; also tag UL

$54.74

0.7 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$98.91

(0.00%)

, CMCSA

Comcast

$33.85

0.03 (0.09%)

16:58
06/17/18
06/17
16:58
06/17/18
16:58
Hot Stocks
Box Office Battle: 'Incredibles 2' breaks record with $180M »

Disney (DIS) and…

TWX

Time Warner

$98.91

(0.00%)

CMCSA

Comcast

$33.85

0.03 (0.09%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$49.11

-0.02 (-0.04%)

FOX

21st Century Fox

$44.57

0.14 (0.32%)

FOXA

21st Century Fox

$44.60

0.03 (0.07%)

LGF.A

Lionsgate

$26.57

1.52 (6.07%)

DIS

Disney

$108.91

0.15 (0.14%)

VIAB

Viacom

$29.40

0.49 (1.69%)

VIA

Viacom

$33.95

0.15 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

OAS

Oasis Petroleum

$12.01

-0.63 (-4.98%)

, OMP

Oasis Midstream Partners

$17.29

-1.02 (-5.57%)

16:46
06/17/18
06/17
16:46
06/17/18
16:46
Conference/Events
JPMorgan to hold a conference »

3rd Annual Energy Equity…

OAS

Oasis Petroleum

$12.01

-0.63 (-4.98%)

OMP

Oasis Midstream Partners

$17.29

-1.02 (-5.57%)

SRCE

1st Source

$55.36

0.13 (0.24%)

LGCY

Legacy Reserves

$6.07

-0.03 (-0.49%)

EVA

Enviva

$29.35

0.15 (0.51%)

CRC

California Resources

$35.03

-2.57 (-6.84%)

INSM

Insmed

$26.74

-1.5 (-5.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 28

    Sep

16:43
06/17/18
06/17
16:43
06/17/18
16:43
Conference/Events
Leerink to hold a tour »

Ribs N' Bones Bus…

16:40
06/17/18
06/17
16:40
06/17/18
16:40
Conference/Events
Citigroup to hold a conference »

2018 European Healthcare…

GM

General Motors

$43.91

0.32 (0.73%)

, FCAU

Fiat Chrysler

$20.86

-0.37 (-1.74%)

16:38
06/17/18
06/17
16:38
06/17/18
16:38
Periodicals
Automakers putting smaller engines into big trucks, WSJ reportsFord »

U.S. auto makers are…

GM

General Motors

$43.91

0.32 (0.73%)

FCAU

Fiat Chrysler

$20.86

-0.37 (-1.74%)

F

Ford

$11.88

-0.01 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

MSFT

Microsoft

$100.24

-1.14 (-1.12%)

, GOOGL

Alphabet Class A

$1,159.03

-1.08 (-0.09%)

16:34
06/17/18
06/17
16:34
06/17/18
16:34
Periodicals
Microsoft is fixing office, WSJ reports »

The new version of…

MSFT

Microsoft

$100.24

-1.14 (-1.12%)

GOOGL

Alphabet Class A

$1,159.03

-1.08 (-0.09%)

GOOG

Alphabet

$1,151.95

-0.05 (-0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 28

    Oct

16:34
06/17/18
06/17
16:34
06/17/18
16:34
Conference/Events
Deutsche Bank to hold a conference »

Taiwan Auto Electronics…

WFC

Wells Fargo

$54.99

0.23 (0.42%)

, MS

Morgan Stanley

$51.17

-0.12 (-0.23%)

16:33
06/17/18
06/17
16:33
06/17/18
16:33
Conference/Events
Federal Reserve Bank of New York to hold a conference »

Reforming Culture &…

WFC

Wells Fargo

$54.99

0.23 (0.42%)

MS

Morgan Stanley

$51.17

-0.12 (-0.23%)

BAC

Bank of America

$29.27

-0.24 (-0.81%)

C

Citi

$66.34

0.18 (0.27%)

WBK

Westpac Banking

$20.67

0.125 (0.61%)

GS

Goldman Sachs

$232.00

-1.695 (-0.73%)

BCS

Barclays

$10.59

-0.225 (-2.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 19

    Jun

  • 21

    Jun

  • 22

    Jun

  • 13

    Jul

  • 10

    Sep

  • 14

    Jan

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 16

    Jul

  • 15

    Oct

  • 15

    Oct

F

Ford

$11.88

-0.01 (-0.08%)

16:25
06/17/18
06/17
16:25
06/17/18
16:25
Hot Stocks
Ford acquires Michigan Central Station »

Ford Motor has acquired…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$54.81

1.165 (2.17%)

16:22
06/17/18
06/17
16:22
06/17/18
16:22
Hot Stocks
Bristol-Myers' ELOQUENT-3 trial meets primary endpoint »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

, RHHBY

Roche

$0.00

(0.00%)

16:18
06/17/18
06/17
16:18
06/17/18
16:18
Hot Stocks
PTC Therapeutics presents updated preliminary data from SMA FIREFISH Program »

PTC Therapeutics (PTCT)…

PTCT

PTC Therapeutics

$37.57

-0.75 (-1.96%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$9.95

0.5 (5.29%)

16:15
06/17/18
06/17
16:15
06/17/18
16:15
Hot Stocks
Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA »

Cytokinetics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$27.92

0.31 (1.12%)

16:12
06/17/18
06/17
16:12
06/17/18
16:12
Hot Stocks
Perry Ellis enters into $437M transaction to become private company »

Perry Ellis International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSTM

Verastem

$6.53

0.95 (17.03%)

16:08
06/17/18
06/17
16:08
06/17/18
16:08
Hot Stocks
Verastem presents duvelisib data at EHA 2018 annual meeting »

Verastem announced one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

IQ

iQIYI

$40.16

-0.44 (-1.08%)

16:05
06/17/18
06/17
16:05
06/17/18
16:05
Hot Stocks
iQIYI obtains broadcasting rights for all four golf majors »

iQIYI announced it had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HD

Home Depot

$200.55

0.86 (0.43%)

15:56
06/17/18
06/17
15:56
06/17/18
15:56
Conference/Events
Home Depot participates in a field trip with UBS »

Field Trip to Atlanta, GA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAY

Verifone

$22.84

0.01 (0.04%)

15:28
06/17/18
06/17
15:28
06/17/18
15:28
Conference/Events
Verifone to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CACI

CACI

$167.60

1.1 (0.66%)

14:18
06/17/18
06/17
14:18
06/17/18
14:18
Conference/Events
CACI to hold a webcast »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

ARGX

Argenx

$92.38

-3.32 (-3.47%)

14:11
06/17/18
06/17
14:11
06/17/18
14:11
Conference/Events
Argenx to hold a KOL breakfast symposium »

Management holds a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

PTC

PTC

$94.87

-0.46 (-0.48%)

14:06
06/17/18
06/17
14:06
06/17/18
14:06
Conference/Events
PTC to host analyst day »

Analyst Day to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:41
06/17/18
06/17
13:41
06/17/18
13:41
Conference/Events
Federal Reserve Bank of Atlanta president speaks at a meeting »

Atlanta Federal Reserve…

VRX

Valeant

$26.86

0.06 (0.22%)

13:31
06/17/18
06/17
13:31
06/17/18
13:31
Conference/Events
Breaking Conference/Events news story on Valeant »

FDA PDUFA Date for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 27

    Aug

WMGI

Wright Medical

$25.83

-0.26 (-1.00%)

13:27
06/17/18
06/17
13:27
06/17/18
13:27
Conference/Events
Wright Medical management to meet with Leerink »

Meeting to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 26

    Jun

  • 12

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.